文献速递贫血与红细胞疾病造血干细胞移植与细胞治疗

重型再生障碍性贫血患者外周血端粒长度与克隆性染色体改变

Telomere length and clonal chromosomal alterations in peripheral blood of patients with severe aplastic anaemia.
PubMed 文献 · Br J Haematol · 2024-08-05

基于再生障碍性贫血移植结局研究数据,分析738例获得性重型再生障碍性贫血患者外周血嵌合染色体改变(mCA)及其与端粒长度和造血细胞移植后生存的关联。患者端粒长度较同龄预期缩短,28.6%检出mCA;chr7缺失者移植后3年生存率低,但多变量分析中短端粒长度而非chr7缺失与更差移植后生存相关。

要点

  • 738例重型再生障碍性贫血患者中28.6%检出嵌合染色体改变,6p拷贝中性杂合性缺失占15.9%。
  • 患者端粒长度较同龄预期缩短,中位端粒长度百分位为35.7。
  • chr7缺失者移植后3年生存概率为39%,多变量分析中短端粒长度与更差移植后生存相关。

核心结论

  • 重型再生障碍性贫血患者端粒长度较同龄预期缩短,嵌合染色体改变常见,短端粒长度与移植后更差生存相关,端粒长度可能指导重型再生障碍性贫血患者的临床决策。

研究设计与样本

  • 利用再生障碍性贫血移植结局研究的数据,纳入738例获得性重型再生障碍性贫血患者,分析外周血嵌合染色体改变及其与端粒长度和造血细胞移植后生存的关联。

主要发现

  • 移植时中位年龄为20.4岁(范围0.2-77.4岁)。
  • 患者端粒长度较同龄预期缩短,中位端粒长度百分位为35.7(范围<1-99.99)。
  • 211例(28.6%)检出嵌合染色体改变,其中chr6p拷贝中性杂合性缺失占15.9%,chr7缺失占3.0%,女性患者中chrX缺失占4.1%。
  • 嵌合染色体改变细胞分数与实测端粒长度呈负相关(r=-0.14,p=0.0002),与遗传预测端粒长度可能呈负相关(r=-0.07,p=0.06)。
  • 移植后3年生存概率在chr7缺失患者中为39%,chr6拷贝中性杂合性缺失患者为72%,其他嵌合染色体改变患者为60%,无嵌合染色体改变患者为70%(p-log rank=0.001)。

关键数值与推荐

  • 多变量分析中,短端粒长度与更差移植后生存相关(p=0.01),chr7缺失与移植后生存的关联未达统计学显著(p=0.29)。

临床怎么用

  • 原文结论提出端粒长度可能指导重型再生障碍性贫血患者的临床决策。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Severe aplastic anaemia (SAA) is a rare and life-threatening bone marrow failure disorder. We used data from the transplant outcomes in aplastic anaemia study to characterize mosaic chromosomal alterations (mCAs) in the peripheral blood of 738 patients with acquired SAA and evaluate their associations with telomere length (TL) and survival post-haematopoietic cell transplant (HCT). The median age at HCT was 20.4 years (range = 0.2-77.4). Patients with SAA had shorter TL than expected for their age (median TL percentile for age: 35.7th; range <1-99.99). mCAs were detected in 211 patients (28.6%), with chr6p copy-neutral loss of heterozygosity (6p-CNLOH) in 15.9% and chr7 loss in 3.0% of the patients; chrX loss was detected in 4.1% of female patients. Negative correlations between mCA cell fraction and measured TL (r = -0.14, p = 0.0002), and possibly genetically predicted TL (r = -0.07, p = 0.06) were noted. The post-HCT 3-year survival probability was low in patients with chr7 loss (39% vs. 72% in patients with chr6-CNLOH, 60% in patients with other mCAs and 70% in patients with no mCAs; p-log rank = 0.001). In multivariable analysis, short TL (p = 0.01), but not chr7 loss (p = 0.29), was associated with worse post-HCT survival. TL may guide clinical decisions in patients with SAA.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Strauss JD, Brown DW, Zhou W, et al. Telomere length and clonal chromosomal alterations in peripheral blood of patients with severe aplastic anaemia. Br J Haematol. 2024. PMID: 39103182. doi:10.1111/bjh.19681

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。